Lotilaner
Ectoparasite control in dogs and cats; ophthalmic use for demodex blepharitis
- CAS No.
- 1369852-71-0
- Indication Class
- Animal Health
- Patent Expiry
- To be assessed
- Therapeutic Area
- Animal Health / Ophthalmology
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- 3 key intermediates available
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higher| Intermediate | CAS | Shared | Action |
|---|---|---|---|
| 2-bromo-3-methyl-5-acetylthiophene | 859199-06-7 | — | |
| 5-acetyl-3-methyl-2-Thiophenecarboxylic acid | 2758907-91-2 | — | |
| methyl 5-acetyl-3-methylthiophene-2-carboxylate | 2758907-87-6 | — |
Listing Logic · Why It's Worth Listing
The only isoxazoline expanded into human ophthalmology (demodex blepharitis), combining a steady animal-health base with a human-use upside option.
Animal Health / Ophthalmology · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
3 key intermediates available; scale-up and cost control manageable
Data File Pack
Product Description
Lotilaner is an ectoparasiticide from the modern isoxazoline class, notable for its unique dual utility. While established in veterinary medicine, it has achieved a groundbreaking milestone as the first FDA-approved drug for a specific human eye condition.
Supply source: Unibest · Lotilaner, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.